Signal Transducer Nanoparticles Enable Siglec-10/G Blockade Immunotherapy for Breast Cancer Treatment
{{output}}
Current treatments for breast cancer (BC), particularly triple-negative BC, are limited in efficacy due to drug resistance and high recurrence rates. CD24, which is highly expressed in BCs and engages with its receptor Siglec-10/G (Siglec-10 in humans and Sigl... ...
